首页> 外文OA文献 >Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

【2h】

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

机译：107例以蒽环类为基础的新辅助化疗治疗的II / III期乳腺癌患者的长期预后和预测因素。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Brain, E.; Garrino, C.; Misset, J. L.; Carbonero, I. G.; Itzhaki, M.; Cvitkovic, E.; Goldschmidt, E.; Burki, F.; Regensberg, C.; Pappo, E.; Hagipantelli, R.; Musset, M.;
展开▼
作者单位

展开▼
年度 1997
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy [J] . E Brain, C Garrino, J-L Misset, British Journal of Cancer . 1997,第9期

机译：蒽环类新辅助化疗治疗107例II / III期乳腺癌患者的长期预后和预测因素
2. Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era [J] . Naomi Nakajima, Masahiko Oguchi, Yasuko Kumai, Advances in Radiation Oncology . 2018,第3期

机译：在现代治疗时代，新辅助化学疗法治疗并接受手术和乳房切除术后放疗的II-III期乳腺癌患者的临床结局和预后因素
3. Prognostic Factors in Patients with Stage II/III Breast Cancer Treated with Adjuvant Extension of Neoadjuvant Chemotherapy: A Retrospective Cohort Study with Ten-Years of Follow-Up Data [J] . Kim Jeryong, Lee Jinsun, Chang Eilsung, Journal of Breast Cancer . 2011,第1期

机译：新辅助化疗辅助扩展治疗II / III期乳腺癌患者的预后因素：一项十年随访资料的回顾性队列研究。
4. Results of treatment in patients with IIa - IIIast. breast cancer treated by combination of low-level laser therapy (LLLT) and surgery (5-year experience) [C] . V.A. Mikhailov, Ctr. of Laser Medicine, Moscow, CIS Selected Papers: Laser Use in Oncology . 1996

机译：IIa-IIIast患者的治疗结果。低水平激光疗法（LLLT）和手术相结合治疗乳腺癌（5年经验）
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. [O] . E. Brain, C. Garrino, J. L. Misset, 1997

机译：107例以蒽环类为基础的新辅助化疗治疗的II / III期乳腺癌患者的长期预后和预测因素。
7. Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era [O] . Naomi Nakajima, Masahiko Oguchi, Yasuko Kumai, 2018

机译：患有Neoadjuvant化疗治疗的阶段III-III乳腺癌患者的临床结果和预后因素，其在现代治疗时代手术和后切除辐射治疗

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

著录项

相似文献

相关主题

期刊订阅